Pramipexole versus Levodopa in Patients with Early Parkinson's Disease: Effect on Generic and Disease-Specific Quality of Life-Reference-Cited by-同舟云学术

Pramipexole versus Levodopa in Patients with Early Parkinson's Disease: Effect on Generic and Disease-Specific Quality of Life

Published:2006-01 Issue:1 Volume:9 Page:28-38
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Noyes Katia,Dick Andrew W.,Holloway Robert G.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference40 articles.

1. Pramipexole vs. levodopa as initial treatment for Parkinson disease: a randomized controlled trial;Parkinson Study Group;JAMA,2000

2. Pramipexole versus levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial;Parkinson Study Group;Arch Neurol,2004

3. A five-year study of the incidence of dyskinesias in patients with early Parkinson's disease who were treated with ropinirole or levodopa;Rascol;N Engl J Med,2000

4. The problem of quality of life in medicine;Leplege;JAMA,1997

5. Assessment of quality of life outcomes;Testa;N Engl J Med,1996

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Occupational Dysfunction as a Factor Affecting Changes in Quality of Life Before and After Hospitalization in Patients with Parkinson's Disease;Asian Journal of Occupational Therapy;2024

3. The dilemma between milestones of progression versus clinical scales in Parkinson's disease;Precision Medicine in Neurodegenerative Disorders, Part I;2023

4. Pramipexole for Treating Parkinson’s Disease;NeuroPsychopharmacotherapy;2022

5. Medical treatment of the motor features of Parkinson disease;Principles and Practice of Movement Disorders;2021